Development in biometric identity verification and management
Post-money valuation โ
$13.2M
As of Oct 2022 ยท from Securlinx Common Stock 1 ยท pre-money + amount raised, not a traded price
Total raised
$167,421
Across 1 round since 2022
Latest share price
$0.25
Securlinx Common Stock 1 offering price
Financials
FY2020โFY2025 ยท from SEC filings ยท hover any figure for its source
$660K
โ$152K
2020
$493K
$107K
2021
$101K
โ$232K
2022
$74K
โ$114K
2023
$42K
โ$73K
2024
$22K
โ$34K
2025
RevenueNet income โ beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$659,925
$492,672
$101,247
$74,338
$41,648
$22,256
Cost of goods sold
$549,755
$8,169
$66,642
$51,540
$45,572
$0
Gross margin
17%
98%
34%
31%
-9%
100%
Net income
-$152,348
$106,847
-$231,760
-$113,556
-$72,775
-$34,269
Taxes paid
$0
$0
$0
$0
$0
$0
Balance sheet
Cash
$2,144
$212,156
$18,690
$12,086
$1,555
$455
Accounts receivable
$0
$1,000
$0
$13,591
$10,788
$13,695
Total assets
$2,144
$1,285,730
$261,700
$287,377
$596,143
$212,650
Short-term debt
$1,455,640
$335,186
$40,096
$72,684
$204,559
$177,924
Long-term debt
$27,400
$1,122,415
$1,811,688
$2,057,653
$1,804,248
$1,992,281
Total liabilities
$1,483,040
$1,457,601
$1,851,784
$2,130,337
$2,008,807
$2,170,205
Other
Headcount
โ
4
4
4
4
4
Figures as reported by the issuer in the filing shown on hover. Each yearโs pill shows the assurance level of its filed statements โ audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didnโt state one. Headcount is the filingโs point-in-time count, not a year-end average. Manually corrected figures are marked โCorrectedโ.
A dashed amber step is a SAFE/note valuation cap โ a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
About this data. Figures are compiled from public sources โ SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages โ and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.